Back to Brevan Howard Capital Management LP Brevan Howard Capital Management LP

NTLANTLA
Showing 8 of 11 quarters

Position history for Brevan Howard Capital Management LPBrevan Howard Capital Management LP's holdings in INTELLIA THERAPEUTICS INC

Brevan Howard Capital Management LP holds 77,951 shares of NTLA (INTELLIA THERAPEUTICS INC), worth $1.3M as of 2026-Q2. The position was increased (+5.5% shares). NTLA represents 0.0% of Brevan Howard Capital Management LP's portfolio.

Current Value

$1.3M

Current Shares

77,951

Total Value Change

+$1M

Total Shares Change

+63,033

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
77,951
+5.5%
$1.3M0.0%$16.92
27
2026-Q1
Increased
73,923
+386.3%
$947,6930.0%$13.60
40
2025-Q4
Decreased
15,202
-76.3%
$136,6660.0%$9.06
0
2025-Q3
Increased
64,154
+190.3%
$1.1M0.0%$16.92
41
2025-Q2
New
22,097
-
$207,2700.0%$9.56
32
2025-Q1
Exited
0
-100.0%
$00.0%$8.07
0
2024-Q4
Increased
108,351
+626.3%
$1.3M0.0%$11.41
41
2024-Q3
New
14,918
-
$306,5650.0%$21.00
32

Other major holders of NTLA: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used